Samantha Bucktrout

Statistics

Publications

Citations

2.6K

H-Index

Active since

2019

Affiliations

Parker Institute for Cancer Immunotherapy(Current)

University of California, San Francisco

Stanford University

The University of Texas MD Anderson Cancer Center

University of California, Los Angeles

Samantha Bucktrout is an author at Parker Institute for Cancer Immunotherapy specializing in cancer immunotherapy, immunotherapy, and cancer immunology.

Publications per year

2019–2025

Publications

Clonal replacement of tumor-specific T cells following PD-1 blockade

Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells et al. · Nature Medicine · 2019 · 1.5K citations

Life Sciences, Cancer Biology, Immunology +16

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 350 citations · Full text

Medicine, Oncology, Pharmacology +15

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary et al. · The Lancet Oncology · 2020 · 301 citations

Medicine, Oncology, Pharmacology +15

Clonal replacement of tumor-specific T cells following PD-1 blockade

Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2019 · 163 citations · Full text

Life Sciences, Cancer Biology, Immunology +16

Characterization and Comparison of GITR Expression in Solid Tumors

Luis M. Vence, Samantha Bucktrout, Irina Fernandez Curbelo et al. · Clinical Cancer Research · 2019 · 60 citations · Full text

Medicine, Immunology, Oncology +15

1–5 of 13